TY - JOUR
T1 - Repeated exposure to cocaine produces long-lasting deficits in the serotonergic stimulation of prolactin and renin, but not adrenocorticotropin secretion
AU - Levy, Andrew D.
AU - Rittenhouse, Peter A.
AU - Bonadonna, Anna M.
AU - Alvarez Sanz, Maria C.
AU - Bethea, Cynthia L.
AU - Van de Kar, Louis D.
PY - 1993/9/14
Y1 - 1993/9/14
N2 - To determine whether cocaine-induced deficits in serotonergic function are long-lasting, the neuroendocrine responses to the serotonin (5-hydroxytryptamine, 5-HT) releaser, p-chloroamphetamine were evaluated 1-8 weeks subsequent to 7 days of cocaine exposure (15 mg/kg b.i.d.). In cocaine-pretreated rats, the p-chloroamphetamine-induced elevations of prolactin and renin secretion were significantly reduced for 8 and 4 weeks, respectively. In contrast, the p-chloroamphetamine-induced elevation of adrenocorticotropic hormone (ACTH) secretion was at control values 1 week after cocaine exposure. The data suggest that some cocaine-induced deficits in serotonergic function are long-lasting.
AB - To determine whether cocaine-induced deficits in serotonergic function are long-lasting, the neuroendocrine responses to the serotonin (5-hydroxytryptamine, 5-HT) releaser, p-chloroamphetamine were evaluated 1-8 weeks subsequent to 7 days of cocaine exposure (15 mg/kg b.i.d.). In cocaine-pretreated rats, the p-chloroamphetamine-induced elevations of prolactin and renin secretion were significantly reduced for 8 and 4 weeks, respectively. In contrast, the p-chloroamphetamine-induced elevation of adrenocorticotropic hormone (ACTH) secretion was at control values 1 week after cocaine exposure. The data suggest that some cocaine-induced deficits in serotonergic function are long-lasting.
KW - 5-HT (5-hydroxytryptamine, serotonin)
KW - ACTH (adrenocorticotropic hormone)
KW - Cocaine (neuroendocrine)
KW - Prolactin
KW - Renin
UR - http://www.scopus.com/inward/record.url?scp=0027296067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027296067&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(93)90215-4
DO - 10.1016/0014-2999(93)90215-4
M3 - Article
C2 - 8243563
AN - SCOPUS:0027296067
SN - 0014-2999
VL - 241
SP - 275
EP - 278
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2-3
ER -